Biomarkerless targeting and photothermal cancer cell killing by surface-electrically-charged superparamagnetic Fe3O4

Xiao Han1, Zicheng Deng1, Zi Yang1

  • 1School of Materials Science and Engineering, Tongji University, Shanghai 200092, PR China and The Institute for Translational Nanomedicine, Shanghai East Hospital, the Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, PR China. yilongwang@tongji.edu.cn donglu.shi@uc.edu.

Nanoscale
|December 13, 2016
PubMed

Insights

This study introduces a novel cancer therapy using positively charged nanoparticles that target cancer cells via their negative surface charge. This method enables biomarker-free, drug-free cancer cell destruction through photothermal hyperthermia.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Targeted cancer therapy faces challenges due to tumor heterogeneity and lack of specific biomarkers.
  • Cancer cells exhibit increased glycolysis, leading to a net negative surface charge distinct from normal cells.
  • Developing biomarker-independent targeting strategies is crucial for effective cancer treatment.

Purpose of the Study:

  • To develop a novel cancer cell targeting and destruction strategy independent of biomarkers.
  • To investigate the use of positively charged superparamagnetic iron oxide (Fe3O4)-composite nanoparticles for cancer cell targeting.
  • To evaluate photothermal hyperthermia as a direct cancer cell killing mechanism mediated by these nanoparticles.

Main Methods:

  • Synthesized positively-charged, fluorescent, superparamagnetic Fe3O4-composite nanoparticles.
  • Exploited the negative surface charge of cancer cells (due to lactate accumulation) for electrostatic nanoparticle binding.
  • Applied 808 nm laser irradiation for photothermal hyperthermia-induced cancer cell death.
  • Utilized negatively-charged nanoparticles as a control to confirm charge-mediated targeting.

Main Results:

  • Positively-charged Fe3O4 nanoparticles selectively bound to cancer cells with negative surface charges.
  • Negatively-charged nanoparticles did not bind to cancer cells due to electrostatic repulsion.
  • Photothermal hyperthermia effectively induced direct cancer cell killing upon nanoparticle binding.
  • The strategy demonstrated successful, biomarker-free, and drug-free cancer cell targeting and destruction.

Conclusions:

  • Positively-charged Fe3O4-composite nanoparticles offer a promising approach for targeted cancer therapy.
  • Electrostatic interaction based on cancer cell surface charge is an effective targeting mechanism.
  • This novel strategy enables direct cancer cell killing via photothermal hyperthermia without biomarkers or drugs.